Menu
// Publications
Posters
Learn more about eTheRNA, our research and development of products.
eTheRNA is present at several conferences. Download our posters presented at those conferences below to get more information about us, our research and developments.
A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity
55th Annual Meeting of the American Society of Clinical Oncology (ASCO), 21-23 May 2019
Multiclonal T cell dendritic cell vaccine immune responses correlate with clinical response in TrimixDC-MEL IPI study, a study with Trimix/tumor antigen mRNA dendritic cells plus ipilimumab in patients with advanced melanoma.
17th Annual Meeting of the Association for Cancer Immunotherapy, 21-23 May 2019
Galileilaan 19, 2845 Niel, Belgium
Our Address
Our Mailbox
+32 3 369 17 40
Our Phone
Menu
© 2020 Etherna | Studio Hanswijk